🟢 Scholar Rock is trading 4.5% up today — immediate catalyst remains unclear

Scholar Rock is trading at $57.79, up 4.45% on September 8, 2026, despite weaker U.S. equities; no verified company-specific announcement has been reported, and the immediate catalyst remains unclear.

• Recent catalysts include FDA Fast Track and Orphan Drug designations for apitegromab’s FSHD program, announced September 2.
• The September 9 Cantor conference may maintain investor attention.
• FDA decision for apitegromab remains scheduled for September 30, 2026.